BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ostios-Garcia L, Villamayor J, Garcia-Lorenzo E, Vinal D, Feliu J. Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer. World J Gastroenterol 2021; 27(40): 6775-6793 [PMID: 34790007 DOI: 10.3748/wjg.v27.i40.6775]
URL: https://www.wjgnet.com/1007-9327/full/v27/i40/6775.htm
Number Citing Articles
1
Dashuai Yang, Fangrui Zhao, Yang Su, Yu Zhou, Jie Shen, Kailiang Zhao, Youming Ding. Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapyFrontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1184708
2
Shuo Jian, Dehua Kong, Jieli Tian. Expression of miR-425-5p in Pancreatic Carcinoma and Its Correlation with Tumor Immune MicroenvironmentJournal of Investigative Surgery 2023; 36(1) doi: 10.1080/08941939.2023.2216756
3
Wenkai Jiang, Caifei Xiang, Yan Du, Xiao Li, Xin Li, Wence Zhou. Time trend of pancreatic cancer mortality in the Western Pacific Region: age-period-cohort analysis from 1990 to 2019 and forecasting for 2044BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11369-1
4
Ying Huang, Zhenhua Yang, Lei Zhang. Polyphenol Supplementation Enhances the Efficacy of PD-1/PD-L1 Inhibitors Against Cancer: A Meta-Analysis of Animal StudiesNutrition and Cancer 2024; 76(1): 17 doi: 10.1080/01635581.2023.2277477
5
Melanie Herpels, Jun Ishihara, Anguraj Sadanandam. The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunitiesThe Journal of Pathology 2023; 260(5): 533 doi: 10.1002/path.6171
6
Zhichen Jiang, Xiaohao Zheng, Min Li, Mingyang Liu. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challengesFrontiers of Medicine 2023; 17(6): 1135 doi: 10.1007/s11684-023-1050-6
7
Haoyang Mi, Shamilene Sivagnanam, Courtney B. Betts, Shannon M. Liudahl, Elizabeth M. Jaffee, Lisa M. Coussens, Aleksander S. Popel. Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic BiomarkersCancer Research 2022; 82(23): 4359 doi: 10.1158/0008-5472.CAN-22-1190
8
Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee, Hyo-Jeong Kuh. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip modelCancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03064-9
9
Xin Xiang, Xuejie Chen, Yue He, Yiwei Wang, Weitong Xia, Shuyu Ye, Sidan Wang, Yi Xiao, Quansi Li, Xiaoyan Wang, Weiwei Luo, Jingbo Li. Pancreatic cancer challenge in 52 Asian countries: age-centric insights and the role of modifiable risk factors (1990-2019)Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1271370
10
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, Zong-Hao Duan, Hong-Fei Yao, Jian Yang, Yong-Wei Sun, Shu-Heng Jiang, De-Jun Liu, Yan-Miao Huo. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironmentCellular Oncology 2023; 46(1): 17 doi: 10.1007/s13402-022-00741-1
11
Irene Pérez-Díez, Zoraida Andreu, Marta R. Hidalgo, Carla Perpiñá-Clérigues, Lucía Fantín, Antonio Fernandez-Serra, María de la Iglesia-Vaya, José A. Lopez-Guerrero, Francisco García-García. A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic MicroenvironmentsCancers 2023; 15(11): 2887 doi: 10.3390/cancers15112887
12
Ana Leda F. Longhini, Inés Fernández-Maestre, Margaret C. Kennedy, Matthew G. Wereski, Shoron Mowla, Wenbin Xiao, Scott W. Lowe, Ross L. Levine, Rui Gardner. Development of a customizable mouse backbone spectral flow cytometry panel to delineate immune cell populations in normal and tumor tissuesFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1374943